CLONIDINE Side Effects

7016148-1 | Agitation, Diarrhoea, Hyperaesthesia, Pain, Polyuria
on Sep 20, 2010 Male patient from , 42 years of age, was diagnosed with pain (What is pain?) and was treated with Clonidine (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, diarrhoea, hyperaesthesia, pain (What is pain?), polyuria. Clonidine dosage: 0.3 Mg. During the same period patient was treated with MORPHINE (9.5 Mg) (View Morphine Review and Morphine Label ), ORAMORPH SR (60-80 Mg) (View Oramorph Sr Review and Oramorph Sr Label ).

7009345-2 | Dizziness, Hypersensitivity, Nausea
Patient was taking Clonidine (View Usage). Patient had the following side effects: dizziness (What is dizziness?), hypersensitivity, nausea (What is nausea?) on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with hypertension and. Clonidine dosage: 0.2 Mg Qd, Via 1/weekly Patch Transdermal.

7006994-2 | Agitation, Device Leakage, Diarrhoea, Hyperaesthesia, Medical Device Complication, Pain, Pollakiuria
Adverse event was reported on Sep 20, 2010 by a Male patient taking Clonidine (View Usage) (Dosage: 0.3 Mg) was diagnosed with pain (What is pain?) and. Location: , 42 years of age, After Clonidine was administered, patient had the following side effects: agitation, device leakage, diarrhoea, hyperaesthesia, medical device complication, pain (What is pain?), pollakiuria. During the same period patient was treated with MORPHINE (9.5 Mg) (View Morphine Review and Morphine Label ), ORAMORPH SR (60-80 Mg) (View Oramorph Sr Review and Oramorph Sr Label ).

7001718-7 | Agitation, Diarrhoea, Hyperaesthesia, Pain, Pollakiuria
on Sep 13, 2010 Male patient from , 42 years of age, was diagnosed with pain (What is pain?) and was treated with Clonidine (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, diarrhoea, hyperaesthesia, pain (What is pain?), pollakiuria. Clonidine dosage: 0.3 Mg. During the same period patient was treated with MORPHINE (9.5 Mg) (View Morphine Review and Morphine Label ), ORAMORPH SR (60-80 Mg) (View Oramorph Sr Review and Oramorph Sr Label ).


6942205-1 | Blood Pressure Increased, Chills, Heart Rate Increased, Peripheral Coldness, Product Adhesion Issue, Unevaluable Event
on Aug 13, 2010 Female patient from UNITED STATES , weighting 200.0 lb, was diagnosed with hypertension and was treated with Clonidine (View Usage). Patient had the following side effects: blood pressure increased, chills, heart rate increased, peripheral coldness, product adhesion issue, unevaluable event. Clonidine dosage: 1/weekly Patch Transdermal; 0.2 Mg Qd, Via 1/weekly Patch Transdermal. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), CATAPRES /00171101/ (View Catapres /00171101/ Review and Catapres /00171101/ Label ).

6933033-1 | Blood Pressure Increased, Product Adhesion Issue
Patient was taking Clonidine (View Usage). After Clonidine was administered, patient had the following side effects: blood pressure increased, product adhesion issue on Aug 18, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 150.0 lb, was diagnosed with hypertension and. Clonidine dosage: 0.1 Mg Patch Lasts 7 Days Transdermal.

6928905-8 | Electrocardiogram P Wave Abnormal, Hypotension
Adverse event was reported on Aug 03, 2010 by a Female patient taking Clonidine (View Usage) (Dosage: 0.2 Mg Three Times Daily) was diagnosed with hypertension and. Location: UNITED STATES , 52 years of age, Patient experienced the following unwanted or unexpected effects: electrocardiogram p wave abnormal, hypotension. During the same period patient was treated with METOPROLOL TARTRATE (200 Mg Twice Daily) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DILTIAZEM HCL (180 Mg Once Daily. Received This Dose Before Admission And On Day 2 Of Admission) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), LABETALOL HCL (20 Mg Once) (View Labetalol Hcl Review and Labetalol Hcl Label ), NIFEDIPINE (Oral Nifedipine Xl 60 Mg) (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized.

6928904-6 | Electrocardiogram P Wave Abnormal, Hypotension
on Aug 03, 2010 Female patient from UNITED STATES , 52 years of age, was diagnosed with hypertension and was treated with Clonidine (View Usage). Patient had the following side effects: electrocardiogram p wave abnormal, hypotension. Clonidine dosage: 0.2 Mg Three Times Daily. During the same period patient was treated with METOPROLOL TARTRATE (200 Mg Twice Daily) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DILTIAZEM HCL (180 Mg Once Daily. Received This Dose Before Admission And On Day 2 Of Admission) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), LABETALOL HCL (20 Mg Once) (View Labetalol Hcl Review and Labetalol Hcl Label ), NIFEDIPINE (Oral Nifedipine Xl 60 Mg) (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized.

6928903-4 | Electrocardiogram P Wave Abnormal, Hypotension
on Aug 03, 2010 Female patient from UNITED STATES , 52 years of age, was diagnosed with hypertension and was treated with Clonidine (View Usage). After Clonidine was administered, patient had the following side effects: electrocardiogram p wave abnormal, hypotension. Clonidine dosage: 0.2 Mg Three Times Daily. During the same period patient was treated with METOPROLOL TARTRATE (200 Mg Twice Daily) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DILTIAZEM HCL (180 Mg Once Daily. Received This Dose Before Admission And On Day 2 Of Admission) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), LABETALOL HCL (20 Mg Once) (View Labetalol Hcl Review and Labetalol Hcl Label ), NIFEDIPINE (Oral Nifedipine Xl 60 Mg) (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized.

6928900-9 | Electrocardiogram P Wave Abnormal, Hypotension
Patient was taking Clonidine (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram p wave abnormal, hypotension on Aug 03, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, was diagnosed with hypertension and. Clonidine dosage: 0.2 Mg Three Times Daily. During the same period patient was treated with METOPROLOL TARTRATE (200 Mg Twice Daily) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DILTIAZEM HCL (180 Mg Once Daily. Received This Dose Before Admission And On Day 2 Of Admission) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), LABETALOL HCL (20 Mg Once) (View Labetalol Hcl Review and Labetalol Hcl Label ), NIFEDIPINE (Oral Nifedipine Xl 60 Mg) (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized.

6916697-8 | Atrioventricular Block First Degree, Atrioventricular Dissociation, Coma, Confusional State, Hypertensive Crisis, Hypotension
Adverse event was reported on Aug 02, 2010 by a Female patient taking Clonidine (View Usage) (Dosage: 600 Mcg) was diagnosed with hypertension, hypertensive crisis and. Location: , 52 years of age, Patient had the following side effects: atrioventricular block first degree, atrioventricular dissociation, coma, confusional state, hypertensive crisis, hypotension. During the same period patient was treated with METOPROLOL (400 Mg) (View Metoprolol Review and Metoprolol Label ), DILTIAZEM (180 Mg) (View Diltiazem Review and Diltiazem Label ), NIFEDIPINE (60 Mg) (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized.

6916692-9 | Convulsion
on Aug 03, 2010 Female patient from , 53 years of age, weighting 154.3 lb, was diagnosed with nerve block and was treated with Clonidine (View Usage). After Clonidine was administered, patient had the following side effects: convulsion. Clonidine dosage: 30 Ml. During the same period patient was treated with ROPIVACAINE (30 Ml Of 0.5%) (View Ropivacaine Review and Ropivacaine Label ).

6885291-X | Aphagia, Asthenia, Dehydration, Depression
on Jul 29, 2010 Male patient from UNITED STATES , 78 years of age, was diagnosed with hypertension and was treated with Clonidine (View Usage). Patient experienced the following unwanted or unexpected effects: aphagia, asthenia, dehydration, depression (What is depression?). Clonidine dosage: 0.1 Mg Bid Po. Patient was hospitalized.

6866895-7 | Blood Pressure Increased
Patient was taking Clonidine (View Usage). Patient had the following side effects: blood pressure increased on Jul 21, 2010 from UNITED STATES Additional patient health information: Male patient , 78 years of age, weighting 185.0 lb, was diagnosed with hypertension and. Clonidine dosage: 1 Tab Twice Daily Mouth.

6856508-2 | Arterial Rupture, Brain Oedema, Cerebrovascular Disorder, Hypertensive Crisis, Product Quality Issue
Adverse event was reported on Jul 16, 2010 by a Female patient taking Clonidine (View Usage) (Dosage: Daily Po) was diagnosed with hypertension and. Location: UNITED STATES , 53 years of age, weighting 155.0 lb, After Clonidine was administered, patient had the following side effects: arterial rupture, brain oedema, cerebrovascular disorder, hypertensive crisis, product quality issue. Patient was hospitalized and became disabled.

6827275-3 | Penile Vascular Disorder
on Jun 28, 2010 Male patient from UNITED KINGDOM , child 4 years of age, weighting 33.07 lb, was diagnosed with epidural anaesthesia, endotracheal intubation, maintenance of anaesthesia, induction of anaesthesia and was treated with Clonidine (View Usage). Patient experienced the following unwanted or unexpected effects: penile vascular disorder. Clonidine dosage: . During the same period patient was treated with ATRACURIUM BESYLATE (0.5 Mg/kg, Unk) (View Atracurium Besylate Review and Atracurium Besylate Label ), LEVOBUPIVACAINE (15 Ml Of 0.25%) (View Levobupivacaine Review and Levobupivacaine Label ), ACETAMINOPHEN (15 Mg/kg, Unk) (View Acetaminophen Review and Acetaminophen Label ), PROPOFOL (4 Mg/kg, Unk) (View Propofol Review and Propofol Label ), SEVOFLURANE (Unk) (View Sevoflurane Review and Sevoflurane Label ). Patient was hospitalized.

6825880-1 | Product Adhesion Issue, Product Substitution Issue
on Jul 08, 2010 Female patient from UNITED STATES , weighting 185.0 lb, was diagnosed with hypertension and was treated with Clonidine (View Usage). Patient had the following side effects: product adhesion issue, product substitution issue. Clonidine dosage: 1 Patch Weekly.

6825829-1 | Product Adhesion Issue, Product Size Issue, Product Substitution Issue
Patient was taking Clonidine (View Usage). After Clonidine was administered, patient had the following side effects: product adhesion issue, product size issue, product substitution issue on Jul 08, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 170.0 lb, . Clonidine dosage: .

6822788-2 | Product Adhesion Issue, Product Size Issue
Adverse event was reported on Jul 06, 2010 by a Female patient taking Clonidine (View Usage) (Dosage: Apply Once A Week; Patch Comes Off) was diagnosed with hypertension and. Location: UNITED STATES , 72 years of age, weighting 124.0 lb, Patient experienced the following unwanted or unexpected effects: product adhesion issue, product size issue.

6800730-8 | Bronchial Secretion Retention, Hypoxia
on Jun 24, 2010 Female patient from , 23 years of age, was treated with Clonidine (View Usage). Patient had the following side effects: bronchial secretion retention, hypoxia. Clonidine dosage: 120 Mcg/h. During the same period patient was treated with MIDAZOLAM HCL (50 Mg/h) (View Midazolam Hcl Review and Midazolam Hcl Label ).

6791347-2 | Penile Vascular Disorder
on Jun 21, 2010 Male patient from , child 4 years of age, weighting 33.07 lb, was diagnosed with epidural anaesthesia, induction of anaesthesia, endotracheal intubation, maintenance of anaesthesia and was treated with Clonidine (View Usage). After Clonidine was administered, patient had the following side effects: penile vascular disorder. Clonidine dosage: 15 Mcg. During the same period patient was treated with PARACETAMOL (15 Mg/kg) (View Paracetamol Review and Paracetamol Label ), PROPOFOL (4 Mg/kg) (View Propofol Review and Propofol Label ), ATRACURIUM (0.5 Mg/kg) (View Atracurium Review and Atracurium Label ), LEVOBUPIVACAINE (15 Ml Of 0.25%) (View Levobupivacaine Review and Levobupivacaine Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

6781615-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Confusional State, Epigastric Discomfort, Haemoglobin Decreased, Urinary Tract Infection
Patient was taking Clonidine (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, confusional state, epigastric discomfort, haemoglobin decreased, urinary tract infection (What is urinary tract infection?) on Jun 17, 2010 from UNITED STATES Additional patient health information: Female patient , 81 years of age, weighting 267.4 lb, . Clonidine dosage: . During the same period patient was treated with ALLEGRA (View Allegra Review and Allegra Label ), ATACAND (View Atacand Review and Atacand Label ), LYRICA (View Lyrica Review and Lyrica Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6767182-8 | Withdrawal Hypertension
Adverse event was reported on Jun 11, 2010 by a Male patient taking Clonidine (View Usage) (Dosage: 0.1 Mg Other Top) . Location: UNITED STATES , 49 years of age, weighting 259.6 lb, Patient had the following side effects: withdrawal hypertension.

6761831-6 | Blood Pressure Increased, Feeling Cold, Heart Rate Increased, Peripheral Coldness, Product Adhesion Issue
on May 21, 2010 Female patient from UNITED STATES , weighting 200.0 lb, was diagnosed with hypertension and was treated with Clonidine (View Usage). After Clonidine was administered, patient had the following side effects: blood pressure increased, feeling cold, heart rate increased, peripheral coldness, product adhesion issue. Clonidine dosage: (df Transdermal), (0.2 Mg Qd, Via 1/weekly Patch Transdermal). During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), CATAPRES /00171101/ (View Catapres /00171101/ Review and Catapres /00171101/ Label ).

6745102-X | Petit Mal Epilepsy
on May 17, 2010 Male patient from UNITED STATES , 17 years of age, weighting 138.9 lb, was diagnosed with insomnia, attention deficit/hyperactivity disorder and was treated with Clonidine (View Usage). Patient experienced the following unwanted or unexpected effects: petit mal epilepsy. Clonidine dosage: 0.1 Mg, Qhs. During the same period patient was treated with CONCERTA (72 Mg, Daily) (View Concerta Review and Concerta Label ).

6738949-7 | Blood Pressure Decreased, Lethargy, Pallor
Patient was taking Clonidine (View Usage). Patient had the following side effects: blood pressure decreased, lethargy, pallor on May 12, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 102.0 lb, was diagnosed with hypertension and. Clonidine dosage: (0.2 Mg Qd, Via 1/weekly Patch Transdermal). During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), COZAAR (View Cozaar Review and Cozaar Label ), DEPAKOTE (View Depakote Review and Depakote Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), LITHIUM (View Lithium Review and Lithium Label ), MELATONIN (View Melatonin Review and Melatonin Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ).

6735631-7 | Product Adhesion Issue
Adverse event was reported on May 20, 2010 by a Female patient taking Clonidine (View Usage) (Dosage: 1 Patch Per Week) was diagnosed with blood pressure (What is blood pressure?) and. Location: UNITED STATES , 56 years of age, weighting 235.0 lb, After Clonidine was administered, patient had the following side effects: product adhesion issue.

6735301-5 | Blood Pressure Inadequately Controlled, Decreased Appetite, Headache, Nausea, Pruritus
on May 13, 2010 Female patient from UNITED STATES , 70 years of age, was diagnosed with hypertension and was treated with Clonidine (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure inadequately controlled, decreased appetite, headache (What is headache?), nausea (What is nausea?), pruritus. Clonidine dosage: 0.1 Mg Qd, Via 1/weekly Patch Transdermal).

6733454-6 | Dermatitis Contact
on May 07, 2010 Female patient from UNITED STATES , 87 years of age, was diagnosed with hypertension and was treated with Clonidine (View Usage). Patient had the following side effects: dermatitis contact. Clonidine dosage: 0.1 Mg Qd, Via 1/weekly Patch Transdermal. During the same period patient was treated with ANAVENOL (View Anavenol Review and Anavenol Label ).

6730980-0 | Hypotension, Hypotonia, Lethargy, Miosis, Respiratory Depression
Patient was taking Clonidine (View Usage). After Clonidine was administered, patient had the following side effects: hypotension, hypotonia, lethargy, miosis, respiratory depression on May 12, 2010 from Additional patient health information: Male patient , child 2 years of age, . Clonidine dosage: .

6723154-0 | Product Adhesion Issue
Adverse event was reported on May 12, 2010 by a Male patient taking Clonidine (View Usage) (Dosage: 1 Patch Weekly) . Location: UNITED STATES , weighting 265.0 lb, Patient experienced the following unwanted or unexpected effects: product adhesion issue.

6720561-7 | Product Adhesion Issue, Product Quality Issue, Product Substitution Issue
on May 11, 2010 Male patient from UNITED STATES , weighting 196.0 lb, was diagnosed with hypertension and was treated with Clonidine (View Usage). Patient had the following side effects: product adhesion issue, product quality issue, product substitution issue. Clonidine dosage: 0.1/24 Hr. 1 Patch Weekly Transdermal.

6715542-3 | Dizziness, Hypertensive Crisis, Hypotension, Vision Blurred
on May 06, 2010 Female patient from UNITED STATES , 42 years of age, weighting 191.8 lb, was diagnosed with hypertension and was treated with Clonidine (View Usage). After Clonidine was administered, patient had the following side effects: dizziness (What is dizziness?), hypertensive crisis, hypotension, vision blurred. Clonidine dosage: 0.2mg/hr Weekly Topical Outpt Dose. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6714485-9 | Accidental Exposure, Depression, Hypotension, Hypotonia, Lethargy, Miosis
Patient was taking Clonidine (View Usage). Patient experienced the following unwanted or unexpected effects: accidental exposure, depression (What is depression?), hypotension, hypotonia, lethargy, miosis on Apr 26, 2010 from CANADA Additional patient health information: Male patient , child 2 years of age, was diagnosed with accidental exposure and. Clonidine dosage: Unk. Patient was hospitalized.

6695457-X | Oedema Peripheral, Pain In Extremity, Product Substitution Issue, Urticaria
Adverse event was reported on Apr 22, 2010 by a Female patient taking Clonidine (View Usage) (Dosage: ) was diagnosed with blood pressure (What is blood pressure?) and. Location: UNITED STATES , weighting 110.0 lb, Patient had the following side effects: oedema peripheral, pain in extremity, product substitution issue, urticaria. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), COREG (View Coreg Review and Coreg Label ), CARDURA (View Cardura Review and Cardura Label ).

6695194-1 | Pyrexia
on Apr 13, 2010 Female patient from UNITED STATES , 66 years of age, was diagnosed with hypertension and was treated with Clonidine (View Usage). After Clonidine was administered, patient had the following side effects: pyrexia. Clonidine dosage: 0.1 To 0.2 Mg, Tid. During the same period patient was treated with DULOXETINE HYDROCHLORIDE (60 Mg, Daily) (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ), ATORVASTATIN (80 Mg, Daily) (View Atorvastatin Review and Atorvastatin Label ). Patient was hospitalized.

6693325-0 | Product Adhesion Issue
on Apr 21, 2010 Male patient from UNITED STATES , 88 years of age, weighting 145.0 lb, was diagnosed with blood pressure (What is blood pressure?) and was treated with Clonidine (View Usage). Patient experienced the following unwanted or unexpected effects: product adhesion issue. Clonidine dosage: 0.2 Mg Daily 1 Patch Weekly Transderma 2-24-10 And Weekly Since + Currently.

6684001-9 | Abdominal Pain, Dizziness, Headache
Patient was taking Clonidine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), dizziness (What is dizziness?), headache (What is headache?) on Jan 18, 2010 from UNITED STATES Additional patient health information: Female patient , 74 years of age, . Clonidine dosage: 1/2 Tablet P.o. Q.i.d.. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), LASIX (View Lasix Review and Lasix Label ), ATIVAN (View Ativan Review and Ativan Label ), COUMADIN (View Coumadin Review and Coumadin Label ), BENICOR (View Benicor Review and Benicor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), OXYGEN (View Oxygen Review and Oxygen Label ).

6682558-5 | Product Adhesion Issue, Product Substitution Issue
Adverse event was reported on Apr 14, 2010 by a Female patient taking Clonidine (View Usage) (Dosage: ) . Location: UNITED STATES , 63 years of age, After Clonidine was administered, patient had the following side effects: product adhesion issue, product substitution issue.

6679959-8 | Blood Creatine Phosphokinase Increased, Pyrexia
on Mar 30, 2010 Female patient from UNITED STATES , 66 years of age, was diagnosed with hypertension, depression (What is depression?), dementia (What is dementia?) and was treated with Clonidine (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, pyrexia. Clonidine dosage: . During the same period patient was treated with ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), DULOXETINE HYDROCHLORIDE (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ), MEMANTINE (View Memantine Review and Memantine Label ), DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6678603-3 | Suicide Attempt
on Apr 12, 2010 Male patient from UNITED STATES , 41 years of age, weighting 220.5 lb, was diagnosed with suicide attempt and was treated with Clonidine (View Usage). Patient had the following side effects: suicide attempt. Clonidine dosage: Po X 1. During the same period patient was treated with PHENYTOIN (Po X 1) (View Phenytoin Review and Phenytoin Label ). Patient was hospitalized.

6678144-3 | Application Site Irritation
Patient was taking Clonidine (View Usage). After Clonidine was administered, patient had the following side effects: application site irritation on Apr 09, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 175.0 lb, was diagnosed with malignant hypertension and. Clonidine dosage: Tts #3 Q Week.

6676297-4 | Application Site Rash, Off Label Use, Product Quality Issue
Adverse event was reported on Mar 19, 2010 by a Male patient taking Clonidine (View Usage) (Dosage: Df Transdermal) was diagnosed with aggression and. Location: UNITED STATES , weighting 105.6 lb, Patient experienced the following unwanted or unexpected effects: application site rash, off label use, product quality issue. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), STRATTERA (View Strattera Review and Strattera Label ).

6674983-3 | Depression, Disturbance In Attention, Impulsive Behaviour, Petit Mal Epilepsy
on Mar 30, 2010 Male patient from , 17 years of age, weighting 138.9 lb, was diagnosed with insomnia, attention deficit/hyperactivity disorder and was treated with Clonidine (View Usage). Patient had the following side effects: depression (What is depression?), disturbance in attention, impulsive behaviour, petit mal epilepsy. Clonidine dosage: 0.1 Mg. During the same period patient was treated with CONCERTA (90 Mg) (View Concerta Review and Concerta Label ), ATOMOXETINE HCL (18 Mg) (View Atomoxetine Hcl Review and Atomoxetine Hcl Label ).

6671463-6 | Blood Pressure Inadequately Controlled, Medical Device Complication, Product Adhesion Issue, Product Substitution Issue
on Apr 06, 2010 Male patient from UNITED STATES , 80 years of age, weighting 200.0 lb, was diagnosed with hypertension and was treated with Clonidine (View Usage). After Clonidine was administered, patient had the following side effects: blood pressure inadequately controlled, medical device complication, product adhesion issue, product substitution issue. Clonidine dosage: 0.3 Mg/day Once / Week Transdermal.

6671081-X | Dystonia, Withdrawal Syndrome
Patient was taking Clonidine (View Usage). Patient experienced the following unwanted or unexpected effects: dystonia (What is dystonia?), withdrawal syndrome on Mar 24, 2010 from UNITED STATES Additional patient health information: Male patient , child 11 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Clonidine dosage: 0.2 Mg, Bid. During the same period patient was treated with METHYLPHENIDATE HYDROCHLORIDE (108 Mg, Daily) (View Methylphenidate Hydrochloride Review and Methylphenidate Hydrochloride Label ), ARIPIPRAZOLE (15 Mg, Bid) (View Aripiprazole Review and Aripiprazole Label ).

6666232-7 | Blood Pressure Systolic Increased, Cough, Dysphagia, Product Adhesion Issue
Adverse event was reported on Mar 15, 2010 by a Female patient taking Clonidine (View Usage) (Dosage: (0.3 Mg Qd, Via 1/weekly Patch Transdermal)) . Location: UNITED STATES , weighting 216.1 lb, Patient had the following side effects: blood pressure systolic increased, cough, dysphagia, product adhesion issue.

6663420-0 | Product Adhesion Issue
on Mar 30, 2010 Male patient from UNITED STATES , 58 years of age, weighting 188.0 lb, was diagnosed with hypertension and was treated with Clonidine (View Usage). After Clonidine was administered, patient had the following side effects: product adhesion issue. Clonidine dosage: One Patch Apply Weekly.

6654272-3 |
on Mar 22, 2010 Female patient from UNITED STATES , 53 years of age, was treated with Clonidine (View Usage). . Clonidine dosage: . During the same period patient was treated with HYDRALAZINE (WATSON LABORATORIES) (View Hydralazine (watson Laboratories) Review and Hydralazine (watson Laboratories) Label ), NIFEDIPINE ER (WATSON LABORATORIES) (View Nifedipine Er (watson Laboratories) Review and Nifedipine Er (watson Laboratories) Label ), BETA BLOCKER (View Beta Blocker Review and Beta Blocker Label ), ANGIOTENSIN CONVERTING ENZYME INHIBITOR (View Angiotensin-converting Enzyme Inhibitor Review and Angiotensin-converting Enzyme Inhibitor Label ), ETHANOL (View Ethanol Review and Ethanol Label ).

6654262-0 |
Patient was taking Clonidine (View Usage). on Mar 22, 2010 from UNITED STATES Additional patient health information: Male patient , 72 years of age, . Clonidine dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), HYDROXYZINE HCL (View Hydroxyzine Hcl Review and Hydroxyzine Hcl Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), CORTISONE (WATSON LABORATORIES) (View Cortisone (watson Laboratories) Review and Cortisone (watson Laboratories) Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ).